Want to get out of your comfort zone and into an adrenaline rush? Our friends at First Descents (FD) provide free, life-changing outdoor adventures for young adults (ages 18-45) living…
Read More
The U.S. Food and Drug Administration has approved Briumvi (ublituximab) as a disease-modifying therapy for adults with relapsing forms of MS. And as of late January, this DMT is now commercially…
There are now several generic versions of the common MS drug Gilenya approved for use in the United States. Patients currently taking Gilenya should be aware that this could impact…
Welcome to a very special edition of Conversations on MS! This session features three MS-specialist neurologists answering frequently asked questions. Dr. John Corboy moderates the event. Corboy is the Medical…
We are saddened to share that Dr. Jack Burks passed away on November 18, 2022. Dr. Burks was a core founder of the Rocky Mountain MS Center, and was at…
COVID-19 continues to twist and turn as new variants become more predominant. The BQ1 and BQ1.1 variants have become the dominant strains in the US as of mid-November. These variants…
NOTE: This information has been adapted from previous updates and is current as of November 8, 2022. >> Before continuing, we suggest you read our list of frequently asked questions with...
Read More
The Rocky Mountain MS Center’s King Adult Day Enrichment Program (KADEP) continues to offer a diverse variety of outings and opportunities through our Adventure Recreation program for KADEP clients. Trips…
The COVID-19 vaccines and boosters remain the best defense against COVID-19. It is very important to receive your vaccine and boosters as soon as possible. Please see our current chart…
NOTE: This information has been adapted from previous updates and is current as of April 11, 2022. Below are answers to some of the frequently asked questions we’ve received recently…